These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16644752)

  • 21. In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations.
    Ogden RT; Ojha A; Erlandsson K; Oquendo MA; Mann JJ; Parsey RV
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):205-17. PubMed ID: 16736050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
    Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
    J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans.
    Frankle WG; Huang Y; Hwang DR; Talbot PS; Slifstein M; Van Heertum R; Abi-Dargham A; Laruelle M
    J Nucl Med; 2004 Apr; 45(4):682-94. PubMed ID: 15073266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The personality trait openness is related to cerebral 5-HTT levels.
    Kalbitzer J; Frokjaer VG; Erritzoe D; Svarer C; Cumming P; Nielsen FA; Hashemi SH; Baaré WF; Madsen J; Hasselbalch SG; Kringelbach ML; Mortensen EL; Knudsen GM
    Neuroimage; 2009 Apr; 45(2):280-5. PubMed ID: 19135154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
    Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
    J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
    Logan J; Ding YS; Lin KS; Pareto D; Fowler J; Biegon A
    Nucl Med Biol; 2005 Jul; 32(5):531-42. PubMed ID: 15982584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.
    Ichise M; Liow JS; Lu JQ; Takano A; Model K; Toyama H; Suhara T; Suzuki K; Innis RB; Carson RE
    J Cereb Blood Flow Metab; 2003 Sep; 23(9):1096-112. PubMed ID: 12973026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Test-Retest Reliability of the SERT Imaging Agent
    Adhikarla V; Dunlop BW; Jarkas N; Goodman MM; Mayberg H; Owens MJ; Nye JA
    J Nucl Med; 2018 Feb; 59(2):315-319. PubMed ID: 28935840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-in-Human Assessment of
    Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
    J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.
    Parsey RV; Slifstein M; Hwang DR; Abi-Dargham A; Simpson N; Mawlawi O; Guo NN; Van Heertum R; Mann JJ; Laruelle M
    J Cereb Blood Flow Metab; 2000 Jul; 20(7):1111-33. PubMed ID: 10908045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Amino-4-(2-((4-[18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies.
    Garg S; Thopate SR; Minton RC; Black KW; Lynch AJ; Garg PK
    Bioconjug Chem; 2007; 18(5):1612-8. PubMed ID: 17705553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications.
    Haeusler D; Mien LK; Nics L; Ungersboeck J; Philippe C; Lanzenberger RR; Kletter K; Dudczak R; Mitterhauser M; Wadsak W
    Appl Radiat Isot; 2009 Sep; 67(9):1654-60. PubMed ID: 19359188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An automated method for the extraction of regional data from PET images.
    Rusjan P; Mamo D; Ginovart N; Hussey D; Vitcu I; Yasuno F; Tetsuya S; Houle S; Kapur S
    Psychiatry Res; 2006 Jun; 147(1):79-89. PubMed ID: 16797168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.
    Huang Y; Hwang DR; Narendran R; Sudo Y; Chatterjee R; Bae SA; Mawlawi O; Kegeles LS; Wilson AA; Kung HF; Laruelle M
    J Cereb Blood Flow Metab; 2002 Nov; 22(11):1377-98. PubMed ID: 12439295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?
    Buchert R; Thiele F; Thomasius R; Wilke F; Petersen K; Brenner W; Mester J; Spies L; Clausen M
    J Psychopharmacol; 2007 Aug; 21(6):628-34. PubMed ID: 17092972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography.
    Yaqub M; Boellaard R; van Berckel BN; Ponsen MM; Lubberink M; Windhorst AD; Berendse HW; Lammertsma AA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1397-406. PubMed ID: 17191076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of non-uniform weighting in non-linear regression for pharmacokinetic neuroreceptor modelling.
    Thiele F; Buchert R
    Nucl Med Commun; 2008 Feb; 29(2):179-88. PubMed ID: 18094641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.